Advertisement
Screener

AMARIN CORP PLC\UK (AMRN) Preferred Stock, Shares Outstanding

2.8 / 5 stars · 68/120 Roast Me

AMARIN CORP PLC\UK Preferred Stock, Shares Outstanding

AMARIN CORP PLC\UK (AMRN) had Preferred Stock, Shares Outstanding of 0 shares as of 2020-12-31, per its 10-K filed 2021-02-25.

Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockSharesOutstanding · last filed 2021-02-25

  • 2020-12-31: Preferred Stock, Shares Outstanding 0.00 shares.
  • 2020-09-30: Preferred Stock, Shares Outstanding 23.85M shares.
  • 2020-06-30: Preferred Stock, Shares Outstanding 51.60M shares.
  • 2020-03-31: Preferred Stock, Shares Outstanding 289.32M shares.
Period endPreferred Stock, Shares Outstanding
2020-12-310.00 shares
10-K · filed 2021-02-25
2020-09-3023.85M shares
10-Q · filed 2020-11-05
2020-06-3051.60M shares
10-Q · filed 2020-08-04
2020-03-31289.32M shares
10-Q · filed 2020-04-30
2019-12-31289.32M shares
10-K · filed 2021-02-25
2019-09-30289.32M shares
10-Q · filed 2019-11-05
2019-06-30289.32M shares
10-Q · filed 2019-07-31
2019-03-31289.32M shares
10-Q · filed 2019-05-01
2018-12-31289.32M shares
10-K · filed 2020-02-25
2018-09-30289.32M shares
10-Q · filed 2018-11-01
2018-06-30328.18M shares
10-Q · filed 2018-08-01
2018-03-31328.18M shares
10-Q · filed 2018-05-02
2017-12-31328.18M shares
10-K · filed 2019-02-27
2017-09-30328.18M shares
10-Q · filed 2017-11-01
2017-06-30328.18M shares
10-Q · filed 2017-08-02
2017-03-31328.18M shares
10-Q · filed 2017-05-03
2016-12-31328.18M shares
10-K · filed 2018-02-27
2016-09-30328.18M shares
10-Q · filed 2016-11-03
2016-06-30328.18M shares
10-Q · filed 2016-08-04
2016-03-31328.18M shares
10-Q · filed 2016-05-05
2015-12-31328.18M shares
10-K · filed 2017-03-01
2015-09-30328.18M shares
10-Q · filed 2015-11-04
2015-06-30289.32M shares
10-Q · filed 2015-08-06
2015-03-31352.15M shares
10-Q · filed 2015-05-08
2014-12-310.00 shares
10-K · filed 2016-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Pulmatrix, Inc. (PULM)United States$0.006B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Ernexa Therapeutics Inc. (ERNA)United States$0.006B